-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On December 2nd news, according to Caihua News Agency, China Renji Medical (00648-HK) announced that it would sell 20% of the shares of Hongdong, a subsidiary of China's medical network business, for RMB 26.
99 million, with an estimated sale proceeds of RMB 1 million.
After completion, the group will continue to be the single largest shareholder of Hongdong.
Hongdong is an investment holding company and is engaged in medical network business in China through its subsidiaries.
For the year ended December 31, 2013, Hongdong had a total consolidated loss before and after tax of RMB 113.
4 million and RMB 120.
8 million.
(natural)
html">force for our army’s first batch of medical aid teams to achieve "zero infection" of medical staff from both sides.